EGFR and interstitial lung disease: Notably, all EGFR-TKIs showed a significant ILD signal (ROR = 24.61), a result that differs from the 0.6%–2.2% incidence reported in previous clinical trials (Takeda et al., 2015), suggesting that the occurrence of ILD may be grossly underestimated in real-world settings.